An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African Community

Completed

• Conditions: Drug Interaction; Drug Reaction; Drug Abuse; Drug Hypersensitivity

• Registration Number: NCT06428162
• Lead Sponsor: Deraya University

Brief Summary

Egypt's several regions-rural, mixed, and urban-were given pre-designed surveys pertaining to drug adverse events and the role of pharmacovigilance in detection and reporting. The three sections of the survey were dedicated to studying health care professionals' knowledge concerning pharmacovigilance concepts and practices, as well as demographics and people reported or not reported. The survey also asked more questions regarding adverse occurrences that were reported.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-02-18
• Primary Completion: 2024-05-20
• Study First Submitted: 2024-05-20
• Study First Submitted QC: 2024-05-20
• Study First Posted: 2024-05-24
• Study Completion: 2024-06-20
• Status Verified: 2024-08
• Last Update Submitted: 2024-08-06
• Last Update Posted: 2024-08-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• all health care providers are invited to share in the study
• minimum experience required is one year in health carrier.
• accept sharing in the study

Read More

Exclusion Criteria

• health care providers who refuse to complete all data required in the survey.
• fresh experience or participants who left health carrier

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
reported adverse drug reactions	3 months	collect recent adverse drug reaction reports

Trial Locations

Locations (1)

Deraya university; 🇪🇬 Minya, Egypt